Medications That Promote Sleep Duration

First-Line Treatment: Non-Pharmacological Approach

The American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as initial therapy before considering pharmacotherapy, demonstrating improvements in total sleep time of 7.61 minutes with sustained effects and no risk of tolerance, dependence, or adverse effects seen with medications 3
CBT-I improves sleep through multiple delivery formats, showing moderate-quality evidence for efficacy 1, 3, 4

Temazepam 15 mg provides the largest improvement in total sleep time: 99 minutes longer than placebo, though it should not be first-line due to unacceptable risk-benefit ratio, particularly in older adults 1, 2
Eszopiclone 2-3 mg improves total sleep time by 28-57 minutes compared to placebo, with moderate-to-large improvement in sleep quality 1, 2
Doxepin 3-6 mg improves total sleep time by 26-32 minutes, particularly effective for sleep maintenance insomnia, reducing wake after sleep onset by 22-23 minutes 1, 2
Zolpidem 10 mg improves total sleep time by 29 minutes, with moderate-quality evidence for improving sleep onset latency and total sleep time 1, 2, 3, 4

The American Academy of Sleep Medicine recommends eszopiclone, doxepin, and zolpidem as first-line pharmacological agents for insomnia, with consideration of patient-specific factors such as age and substance abuse history 1, 2, 3, 4
Ramelteon 8 mg is a valuable first-line option due to minimal adverse effect profile and no dependence risk, primarily benefiting sleep onset latency reduction 4

The American Academy of Sleep Medicine does not recommend diphenhydramine due to lack of efficacy and risks of daytime sedation, delirium, and anticholinergic effects in older adults 1, 4
Melatonin supplement improves total sleep time by only 10.68 minutes, with low-certainty evidence showing little or no effect on primary sleep outcomes 5
Trazodone is not recommended by the American Academy of Sleep Medicine, and should only be used when comorbid depression exists 4
Tiagabine is not effective for insomnia, improving total sleep time by only 1-7 minutes 1

The American College of Physicians recommends identifying sleep complaint pattern, considering patient-specific factors, and using the lowest effective dose for the shortest duration, typically less than 4 weeks for acute insomnia 4, 5
Implementing CBT-I concurrently with pharmacotherapy facilitates eventual medication discontinuation, and transitioning to intermittent dosing rather than nightly use is recommended for patients on long-term hypnotics 6, 4

All hypnotics carry FDA warnings regarding complex sleep behaviors, severe allergic reactions, daytime impairment, and worsening depression 7, 4
Benzodiazepines have black box warnings and should be avoided in older adults and those with cognitive impairment due to falls, fractures, dependence, and cognitive decline 5, 4
Long-term hypnotic use increases dementia risk and serious injury rates, with insufficient evidence to evaluate benefit-harm balance beyond 6-12 months 6